Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Glenmark Pharma

Glenmark Pharma

BSE: 532296|NSE: GLENMARK|ISIN: INE935A01035|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 18, 15:14
365.10
63.9 (21.22%)
VOLUME 1,513,934
LIVE
NSE
Nov 18, 15:14
365.00
64 (21.26%)
VOLUME 36,957,592
News on Glenmark Pharma
Select Year: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Brokerages raise target price of these 10 large, midcap stocks post Q2 results

2.11 pm | 18 Nov 2019 |  Source: Moneycontrol.com

The market traded in a range last week amid weak macro data, but inline performance of India Inc helped the Nifty close near its crucial support of 11...

Glenmark Pharma share price jumps 15% after CLSA upgrades stock to buy

10.13 am | 18 Nov 2019 |  Source: Moneycontrol.com

CLSA is of the view that the US sales momentum is expected to remain strong while India business should continue growing above the industry rate...

Glenmark Pharma share price jumps 4% after Q2 profit at Rs 255 cr

9.56 am | 15 Nov 2019 |  Source: Moneycontrol.com

The net sales of the company stood at Rs 2,763.73 crore, up 8.81 percent, during the period under review as against Rs 2,539.85 crore of the correspon...

Glenmark Pharmaceuticals Q2 net profit at Rs 255.54 cr

8.56 pm | 14 Nov 2019 |  Source: PTI

Net sales of the company stood at Rs 2,763.73 crore, up 8.81 percent, during the period under review as against Rs 2,539.85 crore of the corresponding...

Glenmark Pharma share price gains on final approval from USFDA

10.49 am | 11 Nov 2019 |  Source: Moneycontrol.com

The company's current portfolio consists of 163 products authorized for distribution in the US marketplace and 45 ANDA’s pending approval with t...

Stocks in news: Ashok Leyland, Lupin, Britannia, IDBI Bank, Nila Infra, Laurus Labs

7.54 am | 11 Nov 2019 |  Source: Moneycontrol.com

Aditya Birla Capital | Coal India | Hindalco Industries | CreditAccess Grameen | Aban Offshore and Essel Propack are stocks, which are in news today....

Glenmark recalls over 2 lakh cartons of product in US

12.05 pm | 10 Nov 2019 |  Source: PTI

According to the latest Enforcement Report by the US Food and Drug Administration (USFDA), Glenmark Pharmaceuticals Inc USA is recalling the product i...

Glenmark Pharma gets USFDA nod for prostate cancer treatment drug

11.11 am | 17 Oct 2019 |  Source: PTI

"Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Abiraterone Acetate ta...

Glenmark Q2 PAT may dip 46% YoY to Rs. 132.8 cr: Emkay

4.07 pm | 14 Oct 2019 |  Source: Moneycontrol.com

Net Sales are expected to increase by 2.4 percent Y-o-Y (up 13.8 percent Q-o-Q) to Rs. 2,642.7 crore, according to Emkay....

Glenmark Pharma down 1% despite tentative USFDA nod for multiple sclerosis drug

10.14 am | 09 Oct 2019 |  Source: Moneycontrol.com

The company's portfolio consists of 161 products authorised for distribution in the US marketplace....

Buy Glenmark; target of Rs 500: HDFC Securities

3.40 pm | 20 Aug 2019 |  Source: Moneycontrol.com

HDFC Securities is bullish on Glenmark has recommended buy rating on the stock with a target price of Rs 500 in its research report dated August 16, 2...

Hold Glenmark Pharmaceuticals; target of Rs 410: ICICI Direct

3.19 pm | 16 Aug 2019 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Glenmark Pharmaceuticals with a target price of Rs 410 in its research report dated August 14, 2019....

Glenmark Pharma Q1 net profit at Rs 109 cr

8.49 pm | 13 Aug 2019 |  Source: PTI

The Mumbai-based drug firm said the figures are not comparable as the last financial year included one-time forex gain of Rs 138.21 crore....

Glenmark Pharma Q1 PAT may dip 44.8% YoY to Rs. 151.7 cr: Prabhudas Lilladher

5.00 pm | 12 Jul 2019 |  Source: Moneycontrol.com

Net Sales are expected to increase by 5.6 percent Y-o-Y (down 11 percent Q-o-Q) to Rs. 2,247.9 crore, according to Prabhudas Lilladher....

Hold Glenmark Pharmaceuticals; target of Rs 565: ICICI Direct

12.03 pm | 18 Jun 2019 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Glenmark Pharmaceuticals with a target price of Rs 565 in its research report dated May 30, 2019....

Hold Glenmark Pharmaceuticals; target of Rs 595: Sharekhan

4.43 pm | 03 Jun 2019 |  Source: Moneycontrol.com

Sharekhan recommended Hold rating on Glenmark Pharmaceuticals with a target price of Rs 595 in its research report dated May 30, 2019....

Glenmark Standalone March 2019 Net Sales at Rs 1,587.28 crore, down 4.82% Y-o-Y

1.37 pm | 30 May 2019 |  Source: Moneycontrol.com

NULL...

Glenmark Consolidated March 2019 Net Sales at Rs 2,563.47 crore, up 12.44% Y-o-Y

1.33 pm | 30 May 2019 |  Source: Moneycontrol.com

NULL...

1 2
Quick Links for Glenmark Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.